An official website of the United States government
PAR-24-279 - Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Accelerating Research in Understudied Skin Types | NOT-AR-24-009 | NIAMS | Jul 31, 2023 | Sep 9, 2025 | R21, R01, R34 |
| Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-179 | ODP, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIMH, NIMHD, NINDS, NINR, ODS, ORWH | Jul 14, 2022 | May 8, 2025 | R21, R01, R61/R33, UG3/UH3, R34, U01 |
| Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening | NOT-OD-22-107 | ODP, NIA, NIAAA, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIMH, NIMHD, NINDS, NINR, ODS, ORWH | May 12, 2022 | May 8, 2025 | 333, R01, R34, R21, R61/R33, U01, UG3/UH3 |
For technical issues E-mail OER Webmaster